Tacalyx

Seed
tacalyx.com Biotech & Healthcare Berlin, Germany
Total Funding Undisclosed
Latest Round Undisclosed Seed
Last Announced Apr 29, 2026
Investors Undisclosed
Decision Makers 3 Verified

About Tacalyx

Tacalyx is a biotech company that develops therapies that target cancer by focusing on tumor-associated carbohydrate antigens.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Berlin, Germany
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website tacalyx.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Seed announced

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Tacalyx.

Funding History

1 Round
Seed · Apr 29, 2026
Undisclosed

Founders & Leadership

2

Peter Seeberger

Founder

Work email & phone locked Unlock →

Peter Sondermann

Founder

Work email & phone locked Unlock →

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts